A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors

Clinical trial NCT04009460 · TERMINATED

Trial details

NCT number: NCT04009460
Sponsor: Elpiscience Biopharma, Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Neoplasms Malignant Tumor

Start date: 2019-06-28
Primary completion: 2022-04-22
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.